Lanean...
Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients
AIM: Before pegylated interferon alpha (IFN) was introduced for the therapy of chronic hepatitis C virus (HCV)-induced hepatitis, conventional thrice weekly IFN therapy was supplemented by ribavirin. Also, at that time, higher and more frequent doses of IFN were expected to be more effective than th...
Gorde:
| Argitaratua izan da: | World J Gastroenterol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Baishideng Publishing Group Inc
2005
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436638/ https://ncbi.nlm.nih.gov/pubmed/16273648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i39.6188 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|